Literature DB >> 12413487

A putative DNA-binding domain in the NUCKS protein.

Kirsten Grundt1, Lars Skjeldal, Henrik W Anthonsen, Tormod Skauge, Henrik S Huitfeldt, Anne Carine Østvold.   

Abstract

We have studied the DNA-binding properties of a NUCKS-derived, synthetic peptide containing an extended GRP motif. This peptide binds to random-sequence DNA, but did not bind preferentially to poly(dA-dT). A synthetic peptide with the same amino acid composition but with a random sequence did not bind to DNA, suggesting that the structure of the DNA-binding domain plays a pivotal role in the interaction with DNA. NMR and graphic modeling were employed to investigate the structure of the synthetic peptide. It was shown that the DNA-binding peptide constituted an alpha helix in phosphate buffer at pH 5.5. Docking results indicated an almost perfect fit for this small, helical peptide into the major groove of DNA with the possibility of four basic residues interacting with the phosphate backbone of DNA. One consensus site for phosphorylation by Cdk1 is located in the N-terminal end of the DNA-binding peptide. Upon phosphorylation of this site, the binding to DNA was completely prohibited. Immunofluorescence experiments showed that NUCKS was located in the nuclei in proliferating cells in interphase of the cell cycle, but was distributed throughout the cytoplasm in mitotic cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413487     DOI: 10.1016/s0003-9861(02)00513-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Combined evaluation of the expression of NUCKS and Ki-67 proteins as independent prognostic factors for patients with gastric adenocarcinoma.

Authors:  Ming Yang; Xiaoxia Wang; Qi Zhao; Tianbo Liu; Guodong Yao; Wenhao Chen; Zhiwei Li; Xiaoyi Huang; Yanqiao Zhang
Journal:  Tumour Biol       Date:  2014-05-02

2.  Identification of AMP-activated protein kinase targets by a consensus sequence search of the proteome.

Authors:  Traci L Marin; Brendan Gongol; Marcy Martin; Stephanie J King; Lemar Smith; David A Johnson; Shankar Subramaniam; Shu Chien; John Y-J Shyy
Journal:  BMC Syst Biol       Date:  2015-03-11

3.  Immunohistochemical study of nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 in invasive breast carcinoma of no special type.

Authors:  Krzysztof Symonowicz; Kamila Duś-Szachniewicz; Marta Woźniak; Marek Murawski; Paweł Kołodziej; Beata Osiecka; Kamil Jurczyszyn; Piotr Ziółkowski
Journal:  Exp Ther Med       Date:  2014-07-16       Impact factor: 2.447

4.  NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter.

Authors:  Hye-Young Kim; Byeong-Sun Choi; Sung Soon Kim; Tae-Young Roh; Jihwan Park; Cheol-Hee Yoon
Journal:  Retrovirology       Date:  2014-08-13       Impact factor: 4.602

5.  The NUCKS1-SKP2-p21/p27 axis controls S phase entry.

Authors:  Samuel Hume; Claudia P Grou; Pauline Lascaux; Vincenzo D'Angiolella; Arnaud J Legrand; Kristijan Ramadan; Grigory L Dianov
Journal:  Nat Commun       Date:  2021-11-29       Impact factor: 14.919

6.  Immunohistochemical and proteomic evaluation of nuclear ubiquitous casein and cyclin-dependent kinases substrate in invasive ductal carcinoma of the breast.

Authors:  Piotr Ziółkowski; Elzbieta Gamian; Beata Osiecka; Alexandre Zougman; Jacek R Wiśniewski
Journal:  J Biomed Biotechnol       Date:  2009-12-24

7.  NUCKS1 is a novel RAD51AP1 paralog important for homologous recombination and genome stability.

Authors:  Ann C Parplys; Weixing Zhao; Neelam Sharma; Torsten Groesser; Fengshan Liang; David G Maranon; Stanley G Leung; Kirsten Grundt; Eloïse Dray; Rupa Idate; Anne Carine Østvold; David Schild; Patrick Sung; Claudia Wiese
Journal:  Nucleic Acids Res       Date:  2015-08-31       Impact factor: 16.971

8.  Nucks1 synergizes with Trp53 to promote radiation lymphomagenesis in mice.

Authors:  Yangbo Yue; Stanley G Leung; Yueyong Liu; Yurong Huang; Kirsten Grundt; Anne-Carine Østvold; Kuang-Yu Jen; David Schild; Jian-Hua Mao; Claudia Wiese
Journal:  Oncotarget       Date:  2016-09-20

Review 9.  Roles of NUCKS1 in Diseases: Susceptibility, Potential Biomarker, and Regulatory Mechanisms.

Authors:  Pengru Huang; Yujie Cai; Bin Zhao; Lili Cui
Journal:  Biomed Res Int       Date:  2018-01-29       Impact factor: 3.411

10.  NUCKS1 promotes RAD54 activity in homologous recombination DNA repair.

Authors:  David G Maranon; Neelam Sharma; Yuxin Huang; Platon Selemenakis; Meiling Wang; Noelia Altina; Weixing Zhao; Claudia Wiese
Journal:  J Cell Biol       Date:  2020-10-05       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.